scispace - formally typeset
A

Amit Joshi

Researcher at Harvard University

Publications -  497
Citations -  18902

Amit Joshi is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 57, co-authored 390 publications receiving 12207 citations. Previous affiliations of Amit Joshi include VA Boston Healthcare System & Stanford University.

Papers
More filters
Journal ArticleDOI

Genetic architectures of proximal and distal colorectal cancer are partly distinct.

Jeroen R. Huyghe, +165 more
- 25 Feb 2021 - 
TL;DR: In this article, the authors identify new anatomical subsite-specific risk loci for colorectal cancer and characterised effect heterogeneity at CRC risk locis using multinomial modeling.
Journal ArticleDOI

Clinical Outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional Cancer.

TL;DR: This article is a retrospective analysis of patients who received weekly paclitaxel 50 mg/m2 and carboplatin AUC 2 with radical definitive RT for locally advanced esophageal/GEJ cancer, finding weekly pac litaxel–carboplatin concurrently with definitive RT is efficacious with manageable toxicity.
Journal ArticleDOI

Testing calibration of risk models at extremes of disease risk.

TL;DR: A new approach to test model calibration targeted toward extremes of disease risk distribution where standard goodness-of-fit tests may lack power due to sparseness of data is proposed.
Journal ArticleDOI

Ultrasensitive carbohydrate-peptide SPR imaging microarray for diagnosing IgE mediated peanut allergy.

TL;DR: This work reports here the first immunoarray for IgEs utilizing both peptide and carbohydrate epitopes from major peanut allergen glycoprotein Arachis hypogaea h2 (Ara-h2) and correlated with standard ImmunoCAP values.
Journal ArticleDOI

Mendelian randomization analysis of C-reactive protein on colorectal cancer risk

Xiaoliang Wang, +68 more
TL;DR: It is suggested that circulating CRP is unlikely to be a causal factor in CRC development, despite adequate statistical power to detect moderate association.